|
WO2021055352A1
|
|
Methods and compositions for preserving bacteria
|
|
WO2021030198A1
|
|
Compositions and methods for suppressing pathogenic organisms
|
|
AU2019321681A1
|
|
Methods of decreasing dysbiosis and restoring a microbiome
|
|
WO2019143883A2
|
|
Compositions and methods for the treatment of cancer
|
|
US2019134107A1
|
|
Compositions and methods for the treatment of allergy
|
|
EP3723776A2
|
|
Compositions and methods for suppressing pathogenic organisms
|
|
CA3081978A1
|
|
Compositions and methods for the treatment of allergy
|
|
EP3554520A1
|
|
Methods and compositions for determining bacterial integrity
|
|
CA3041677A1
|
|
Methods and compositions for preserving bacteria
|
|
US2018000921A1
|
|
Compositions containing combinations of bioactive molecules derived from microbiota for treatment of disease
|
|
US2017354697A1
|
|
Treatment of clostridium difficile infection
|
|
AU2017285211A1
|
|
Treatment of clostridium difficile infection
|
